Literature DB >> 22578760

A comparison of precipitants and mortality when acute decompensated heart failure occurs in the community and hospital settings.

D McD Taylor1, M Ng Tang Fui, A R Chung, L Gani, J D Zajac, L M Burrell.   

Abstract

AIM: We aimed to compare the precipitants of acute decompensated heart failure (ADHF) among patients admitted with diagnoses inclusive of ADHF (community patients) and patients admitted without ADHF but who developed it during their stay (hospital patients).
METHODS: This was a prospective, analytical, observational study undertaken in the Austin Hospital, a major metropolitan teaching hospital (September 2008-February 2010). Consecutive patients admitted to a general medicine unit, and diagnosed and treated for ADHF were enrolled. The unit medical staff completed a specifically designed data collection document.
RESULTS: Three hundred and fifty-nine patients were enrolled (42.9% male, mean age 81.9 years). The community (n=312) and hospital (n=47) patient groups did not differ in age, gender, risk variables (living alone, cognitive impairment, multiple medications, compliance), cardiac failure medication use or cause of known heart failure (ischaemia, hypertension, valve dysfunction, 'other') (p>0.05). The ADHF precipitants comprised infection (39.8% patients), myocardial ischaemia (17.3%), tachyarrhythmia (16.2%), non-compliance with fluid and salt restriction (9.2%), non-compliance with medication (6.7%), renal failure (5.8%), medication reduction (5.0%), intravenous fluid complication (3.9%) and 'other' causes (13.9%). Significantly more hospital patients had their ADHF precipitated by intravenous fluid complications (25.5% versus 0.6%, p<0.001). Hospital patients also had a significantly greater death rate (25.5% versus 9.3%, p<0.01).
CONCLUSION: Acute decompensated heart failure precipitated in hospital is a dangerous condition with a high mortality. While infection and myocardial ischaemia are the common precipitants, complications of intravenous fluid use, an iatrogenic condition, may be considerable and are potentially avoidable.
Copyright © 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22578760     DOI: 10.1016/j.hlc.2012.04.008

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

Review 1.  Heart failure in very old adults.

Authors:  Daniel E Forman; Ali Ahmed; Jerome L Fleg
Journal:  Curr Heart Fail Rep       Date:  2013-12

2.  European Society of Cardiology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department.

Authors:  Òscar Miró; Frank W Peacock; John J McMurray; Héctor Bueno; Michael Christ; Alan S Maisel; Louise Cullen; Martin R Cowie; Salvatore Di Somma; Francisco J Martín Sánchez; Elke Platz; Josep Masip; Uwe Zeymer; Christiaan Vrints; Susanna Price; Alexander Mebazaa; Christian Mueller
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-02-21

3.  Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.

Authors:  John T Parissis; Chiara Andreoli; Nikolaos Kadoglou; Ignatios Ikonomidis; Dimitrios Farmakis; Ioanna Dimopoulou; Efstathios Iliodromitis; Maria Anastasiou-Nana; Mitja Lainscak; Giussepe Ambrosio; Alexandre Mebazaa; Gerasimos Filippatos; Ferenc Follath
Journal:  Clin Res Cardiol       Date:  2014-04-10       Impact factor: 5.460

4.  Characteristics and outcomes of patients with acute decompensated heart failure developing after hospital admission.

Authors:  Mehul D Patel; Corey A Kalbaugh; Patricia P Chang; Kunihiro Matsushita; Sunil K Agarwal; Melissa C Caughey; Hanyu Ni; Wayne D Rosamond; Lisa M Wruck; Laura R Loehr
Journal:  Am J Cardiol       Date:  2014-08-27       Impact factor: 2.778

Review 5.  Polypharmacy definition and prevalence in heart failure: a systematic review.

Authors:  Janine Beezer; Manal Al Hatrushi; Andy Husband; Amanj Kurdi; Paul Forsyth
Journal:  Heart Fail Rev       Date:  2021-07-02       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.